Ethnicity Does Not Affect the Homocysteine-Lowering Effect of B-Vitamin Therapy in Singaporean Stroke Patients
Author(s) -
Katherine Kasiman,
John W. Eikelboom,
Graeme J. Hankey,
Samantha P.-K. Lee,
Joanna P.-Z. Lim,
Jasinda H. Lee,
HuiMeng Chang,
MengCheong Wong,
Christopher Chen
Publication year - 2009
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.108.535237
Subject(s) - medicine , methylenetetrahydrofolate reductase , homocysteine , b vitamins , ethnic group , stroke (engine) , placebo , population , vitamin , risk factor , gastroenterology , genotype , biochemistry , pathology , environmental health , biology , mechanical engineering , alternative medicine , sociology , gene , anthropology , engineering
Increased total homocysteine (tHcy) is a risk factor for stroke. This study examines whether the efficacy of B-vitamins in reducing tHcy is modified by ethnicity in a Singaporean ischemic stroke population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom